Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Doctors discovered a huge bladder stone, as big as a baseball, when performing an ultrasound on a 72-year-old woman who was ...

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged ...

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

St. Bernards Medical Center has successfully performed Arkansas' first noninvasive treatment of early-stage prostate cancer.

Fusion biopsy industry is projected to witness a CAGR of 9.9% during the period 2025-2034. This growth can be attributed to ...

Prostate Artery Embolization (PAE) offers a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). Suitable for ...

Learn how a novel treatment option can reduce traditional side effects.